...
首页> 外文期刊>World journal of engineering >Association of vaccine medication for the efficacious COVID-19 treatment
【24h】

Association of vaccine medication for the efficacious COVID-19 treatment

机译:疫苗药物与有效 COVID-19 治疗的关联

获取原文
获取原文并翻译 | 示例
           

摘要

PurposeThe present digital world's challenging issue is COVID-19. This paper is related to the process of the COVID-19 treatment based on age, gender, symptoms and previous health issues. This paper gives the deep discussion about the prevention, symptoms, tests and treatment process. In this research work, the discussion is about vaccine invention and the side effects of the consumed medication.Design/methodology/approachThis paper gives a clear explanation of the types of vaccine, which are lopinavir, ritonavir, remdesivir, hydroxychloroquine, chloroquine and plasma therapy. Thereafter, the discussion is prolonged to Indian vaccine for COVID-19.FindingsThis paper examines some of the COVID-19 treatment processes and difficulties, and finally, this paper aims to summarize and give an overview of the present preclinical research and clinical trials of potential candidates for COVID-19 treatments and vaccines.Originality/valueThe required information has been taken from online databases such as PubMed, Science, Nature, PNAS and Cell. Papers included were published between December 2019 and July 2020. The current results indicate the most promising outcomes for dexamethasone as a treatment and vaccine. Further research is needed to identify safe and effective treatments and vaccines for COVID-19.
机译:目的当前数字世界具有挑战性的问题是 COVID-19。本文与基于年龄、性别、症状和既往健康问题的 COVID-19 治疗过程有关。本文对预防、症状、检测和治疗过程进行了深入讨论。在这项研究工作中,讨论的是关于疫苗发明和食用 medication.Design/methodology/approachThis 的副作用,论文清楚地解释了疫苗的类型,即洛匹那韦、利托那韦、瑞德西韦、羟氯喹、氯喹和血浆疗法。此后,讨论扩展到印度的 COVID-19 疫苗。研究结果本文探讨了 COVID-19 的一些治疗过程和难点,最后,本文旨在总结和概述目前 COVID-19 治疗和疫苗潜在候选药物的临床前研究和临床试验。原创性/价值所需信息取自 PubMed、Science、Nature、PNAS 和 Cell 等在线数据库。收录的论文发表于2019年12月至2020年7月之间。目前的结果表明,地塞米松作为治疗和疫苗最有希望的结果。需要进一步的研究来确定安全有效的COVID-19治疗方法和疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号